Introduction: Amiodarone, a frequently used antiarrhythmic drug in cardiology, is very effi cient in the treatment of ventricular and supraventricular tachiarrithmyas. The iodine content of amiodarone is 39%. Its chemical structure is similar to tyrosine. It is estimated that 1-23% of patients treated with amiodarone can develop hyperthyroidism. The purpose of this study is to assess and monitor the incidence of hyperthyroidism induced by amiodarone in patients admitted for various types of cardiac dysrhythmias, considering that most of the patients included in the study came from an endemic goitre area. Material and method: One-hundred patients chosen systematically (62 men, 38 women) from 560 patients treated with amiodarone in the January 1 st , 2009 -December 31, 2009 period were assessed (clinically, laboratory fi ndings and imaging studies); their mean age was 64 years (range 50-70 years). In order to identify and diagnose hyperthyroidism, a questionnaire (Newcastle index) was used, also urinary iodine dosage, hormonal dosages (T3, T4, TSH) and thyroid imaging (ultrasound, radioactive iodine uptake test) were used. Results: The incidence of hyperthyroidism induced by amiodarone in this study was 8%. Hyperthyroidism was more frequent in women (6 women vs. 2 men). Conclusions: Thyroid hormonal levels have to be determined and a clinical or thyroid ultrasound examination should be made prior to initiating a treatment with amiodarone. At the end of the study, 8 patients, most of them female, were diagnosed with hyperthyroidism.
Introduction
Iodine is indispensible for thyroid hormonogenesis. Th e quantity of iodine in the body is one of the most important factors in thyroid function adjustment. It is estimated that 1-23% of patients treated with amiodarone can develop hyperthyroidism [1, 2] .
Two physiopatological mechanisms of hyperthyroidism correlated with an increased intake of iodine have been observed:
-aggravated hyperthyroidism due to iodine excess in patients with thyroid pathology, and -iodine induced hyperthyroidism that occurs in case of patients without known thyroid pathology [2, 3] . Due to isotope dilution there is a low iodine capture level in all iodine charges, but in patients with existing thyroid pathology, iodine capture is not as low as previous research shows [4, 5, 6] .
Th e diagnosis of hyperthyroidism through iodine overcharge is suggested by the patient's history: iodine agents used in practice or used in investigations [7] . Th e diagnosis can be confi rmed by total iodine dosage or by iodine measurement. Th e iodine charge is confi rmed when iodine blood levels exceed 400 μg/24 hours and the measurement is useful since it confi rms the patient's history, as well as the suspicion of thyrotoxicosis due to an increased intake [8] .
Th yroid hormone dosage is important because amiodarone diminishes the metabolic clearance of T4 (thyroxine) and the peripheral conversion of T4 in T3 (triiodothyronine) and increases the total and free T4 concentration, and the T3 concentration remains normal or lowers. Th e diagnosis of hyperthyroidism is based on the low circulating TSH (thyroid stimulating hormone) levels and on the absence of its response after stimulation with TRH (thyroid releasing hormone) [9, 10, 11] .
Th e purpose of this study is to assess and monitor the incidence of hyperthyroidism induced by amiodarone in patients admitted for various types of cardiac dysrhythmias, considering that the patients included in the study came from an endemic goitre area.
Material and method
Th e study was approved by the Ethics Committee of the University of Medicine and Pharmacy of Tîrgu Mureș, Romania, and was performed in the accordance with sthe tandards of the Declaration of Helsinki. Written consent for using the patient's data in the present study was obtained from all patients. No procedures beyond the standard of care were performed specifi cally for the purposes of this study.
For this study, 560 patients met the inclusion criteria: all of them were treated with amiodarone at the site of the study, for a period of 6 months for diff erent cardiac dysfunctions: dilatative cardiomiopathy, angina pectoris,
Correspondence to: Arthur Atilla Keresztesi E-mail: ar2r_a23@yahoo.com atrial fl utter with variable blockage, sinus node dysfunction, chronic atrial fi brillation (AF) with medium ventricular rate, paroxysmal AF with high ventricular rate, ventricular premature beats (ventricular extrasystoles), sustained ventricular tachiarrithmyas, acute myocardial infarction.
Th e group of 560 patients was hospitalized between January 1 st , 2009 -December 31, 2009. Th e patients were inserted in a database, in the order of their hospitalization date and every 5 th or 6 th patient was chosen. At the end of the process, 100 patients were systematically chosen from the group and included in the study (Figure 1) . Some of the patients were from another county, and their progress could not be thoroughly followed, therefore in some cases the 6 th and not the 5 th patient was included in the study. For simpler data analysis and statistical calculus, only 100 patients were chosen.
Th e Newcastle index was applied to all 100 patients to determine the clinical grounds for hyperthyroidism diagnosis. For scores smaller than 10 the thyroid function is considered to be normal, for scores between 11 and 19 there is a possible hyperthyroidism, while for scores over 20 the diagnosis of hyperthyroidism is certain.
After the Newcastle index was calculated for all patients, those with possible hyperthyroidism were subjected to a series of blood tests to determine the level of thyroid hormones TSH, T3 and T4, thyroid ultrasound, radioactive iodine uptake test (RAIU test), cholesterol levels, achilean refl exograme, iodine urine levels (rapid urinary iodide test kit by Merck KGaA, Darmstadt, Germany).
Results
Out of the 100 patients treated with amiodarone, 62 were male and 38 female. Th e average age of these 100 patients was 64 years, with ages ranging from 50 to 70 years.
Th e interpretation of Newcastle index results, regarding hyperthyroidism diagnosis, revealed the following:
-78 patients had no specifi c symptoms for hyperthyroidism (Newcastle score under 10); -18 patients presented clinical signs and symptoms for hyperthyroidism (Newcastle score between 11 and 19); -4 patients had Newcastle scores higher than 20. For further assessment of the Newcastle's score sensitivity, clinical investigations were carried out for the 22 patients suspected of thyroid dysfunction (with a score over 10). Th e results confi rmed 8 (36.4%) patients with hyperthyroidism, 6 female and 2 male.
Out of the 8 patients with confi rmed thyroid dysfunction, 4 had high Newcastle score and 4 had a medium Newcastle score (11) (12) (13) (14) (15) (16) (17) (18) (19) .
Discussions
In the present study, the incidence of amiodarone induced hyperthyroidism was 8%, all patients were over 50 years old, the average age being 64 years. Th yroid dysfunction was more frequent in women. An important aspect to mention is that all patients came from areas with iodine defi ciency. A similar incidence of thyroid dysfunction induced by amiodarone had been found in another Romanian study [13] . Th e 8% incidence found in the present study is representative for the Transylvania region, this being a known goitre endemic area. It is worth mentioning that recently there have not been other studies carried out in this area.
Although the Newcastle index indicated that 22 patients might have hyperthyroidism, only 8 were confi rmed. 100% of those with high score were confi rmed, thus, for this group of patients the Newcastle index has been reliable, but in case of medium scores (11) (12) (13) (14) (15) (16) (17) (18) (19) , the Newcastle index has proved to be irrelevant in the present study (22% had confi rmed hyperthyroidism). A smaller incidence of amiodarone induced hyperthyroidism of only 3% has been noted in a study conducted by Hoff man et al in 2008 [12] . While the male:female ratio in the aforementioned study was 3:1, in our study it was 1:3. In both studies, most patients were older than 55 years.
Radioactive iodine uptake test proved to be of assistance in diagnosing a thyroid adenoma in 4 patients. Iodine capture was low or absent in 4 other cases, but correlated with the clinical symptoms of hyperthyroidism, this being characteristic for thyroid dysfunction induced by excess iodine. In determining the etiology of the hyperthyroidism, thyroid ultrasound did not prove to be of assistance, except for diagnosing hyperechogenic nodules. Hormone dosage was an essential method to confi rm the suspicion of hyperthyroidism: T3, T4 with values above normal and low TSH.
Th yroid dysfunction was reported between 3 and 6 months after initiating amiodarone treatment. A possible explanation of this delay is that prior to initiating amiodarone treatment, no investigations concerning the thyroid function were carried out. Th e treatment of the thyroid dysfunction consisted in amiodarone stoppage and administration of betablockers. In a study conducted by Lambert et al [14] on 24 patients, it has been found that after 1-4 months of amiodarone treatment, serum T4 levels incresead by an average of 40% above the pretreatment levels, in some cases the elapsed time between the fi rst symptoms and paraclinical modifi cations being shorter than in our study. Conclusions 1. Th e incidence of hyperthyroidism in this study was 8%.
All patients came from areas with iodine defi ciency.
2. Women were more often aff ected than men and in all patients with high Newcastle index diagnosis of hyperthyroidism was clinically confi rmed. 3. An important practical aspect to keep in mind before initiating amiodarone treatment is at least to determine the thyroid hormone level, to conduct a clinical examination and thyroid ultrasound, due to the amiodarone's increased iodine content which may lead to hyperthyroidism.
